SWK (NASDAQ:SWKH) Posts Quarterly Earnings Results, Beats Estimates By $0.25 EPS

SWK (NASDAQ:SWKH) posted its earnings results on Thursday. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.25, Zacks reports. SWK had a net margin of 39.00% and a return on equity of 8.43%.

SWK Trading Up 2.1%

Shares of SWKH traded up $0.35 during mid-day trading on Thursday, reaching $16.68. The stock had a trading volume of 51,233 shares, compared to its average volume of 19,505. The company has a debt-to-equity ratio of 0.13, a current ratio of 3.17 and a quick ratio of 3.17. SWK has a 52-week low of $13.17 and a 52-week high of $20.49. The business’s fifty day moving average is $15.32 and its 200 day moving average is $14.89. The firm has a market cap of $202.61 million, a price-to-earnings ratio of 11.75 and a beta of 0.22.

Institutional Investors Weigh In On SWK

A number of hedge funds have recently modified their holdings of the company. Bridgeway Capital Management LLC grew its holdings in shares of SWK by 2.9% in the second quarter. Bridgeway Capital Management LLC now owns 114,277 shares of the company’s stock valued at $1,684,000 after purchasing an additional 3,263 shares during the period. Bank of America Corp DE boosted its stake in SWK by 41.8% during the second quarter. Bank of America Corp DE now owns 5,595 shares of the company’s stock worth $82,000 after buying an additional 1,649 shares during the period. Raymond James Financial Inc. boosted its stake in SWK by 297.5% during the second quarter. Raymond James Financial Inc. now owns 74,657 shares of the company’s stock worth $1,100,000 after buying an additional 55,874 shares during the period. Finally, Empowered Funds LLC boosted its stake in SWK by 3.7% during the first quarter. Empowered Funds LLC now owns 53,809 shares of the company’s stock worth $936,000 after buying an additional 1,929 shares during the period. Hedge funds and other institutional investors own 99.27% of the company’s stock.

Wall Street Analyst Weigh In

SWKH has been the subject of a number of research analyst reports. Wall Street Zen cut shares of SWK from a “buy” rating to a “hold” rating in a research report on Sunday, September 21st. Maxim Group cut shares of SWK from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 13th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of SWK in a research report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $18.00.

SWK Company Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.